Fujita Health University releases a preliminary report of Favipiravir Observational Study

Favipiravir (brand name Avigan) Observational Study Group (principal investigator: Dr. Yohei Doi, Fujita Health University) released a preliminary report of the Favipiravir Observational Study in Japan on the Japanese Association for Infectious Diseases website. This preliminary report contains entries made to the study database by COB May 15, 2020, consisting of 2,158 patients who received favpiravir for COVID-19 and describes their background, clinical course, outcome and adverse events.